Изучение взаимосвязи уровня аполипопротеина Е и полиморфизма его гена с выраженностью каротидного атеросклероза и коронарной болезни сердца у мужчин-кыргызов с дислипидемией
Диссертация
Ранее проводимые научные исследования в нашей республике выявили-этнические особенности в распределении спектра липопротеинов (ЛП) и аполипопротеинов у пациентов кыргызскойнациональности (Айтбаев К.А., 1990). В частности, было показано, что этнические кыргызы имеют более низкое содержание атерогенных липидных фракций в сыворотке крови по сравнению с аналогичной русской, группой. В развитии… Читать ещё >
Список литературы
- Айтбаев К.А. Влияние адаптапции к условиям высоты и характера питания на параметры липидного метаболизма и распространенность ишемической болезни сердца в Киргизской ССР / К. А. Айтбаев: Автореф. дис. д-ра мед. наук. Москва, 1990. — 42 с.
- Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению / С. А. Бутрова // РМЖ 2001. — Т.9, № 2. -С. 56−61.
- Виноградова С.В. Роль полиморфизма эпсилон2/эпсилонЗ/эпсилон4 гена аполипопротеина Е в развитии атеросклероза / С. В. Виноградова // Медицинская генетика. 2006. — Т.5, № 2. — С. 3 — 10.
- Этногенетические особенности подверженности атеросклерозу в этнических группах Сибири (на примере гена аполипопротеина Е) / М.И.
- Воевода, В.А. Степанов, А.Г. Ромащенко, В. Н. Максимов // Бюллетень СО РАМН. -2006. -№ 2. (120).-С. 63−72.
- Доборджгинидзе JI.M. Дислипидемии: липиды и липопрогеины, метаболизм и участие в атерогенезе / JI.M. Доборджгинидзе, Н. А. Грацианский // РМЖ. 2000. — № 8. — С. 7.
- Миррахимов Э.М. Основные принципы диагностики и лечения дислипидемий / Э. М. Миррахимов. Бишкек, 2002.-308 с.
- Мясников A.JI. Атеросклероз / A.JI. Мясников. Москва, 1960.
- Панин JI.E. Стресс, сердце и сосуды / JLE. Панин // Вопросы атерогенеза. Новосибирск, 2005. — С. 20 — 34.
- Синицина Т.А. Экспериментальный атеросклероз коронарных артерий сердца / Т. А. Синицина. JL, 1964.-168 с.
- Справочник Национального статистического комитета КР «Причины смертности населения в Кыргызской Республике» Бишкек, 2005, с.164−166.
- Фрагмент аполипопротеина В с инсулиноподобиой иммунореактивностью / JI.E. Панин, О. Н. Потеряева, О. С. Воронова и др. // Проблемы эндокринологии. 2002. — Т.48, № 1. — С.6 — 9.
- Anderson К.М. Cholesterol and mortality: 30 years of following up from the Framingham Study / K.M. Anderson, W.P. Castelly, D. Levy // JAMA. -1987. Vol. 257.-P.2176.
- Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis / M. de A’ndrade, I. Thandi, S. Brown, A. Gotto et.al. // Am. J. Hum. Genet 1995. Vol. 56. — P. 1379−90.
- Polymorphisms of apolipoprotein E and angiotensin-converting enzyme genes and carotid atherosclerosis in heavy drinkers / M. Bednarska-Makaruk, M. Rodo, C. Markuszewski, A. Rozenfeld et.al. // Alcohol & Alcoholism.- 2005. Vol. 40. — P.274−282.
- Heritabilities of apolipoprotein and lipid levels in three countries / M. Beekman, B.T. Heijmans, N.G. Martin, N.L. Pedersen et.al. // Twin. Res. 2002. Vol. 5. — P.87−97.
- Macrophage-specific expression of human apolipoprotein E reduces atherosclerosifs in hypercholesterolemic apolipoprotein E-null mice / S. Bellosta, R.W. Mahley, D.A. Sanan, J. Murata et.al. // J. Clin. Invest. 1995. Vol. 96.-P.2170−2179.
- Boerwinkle E. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism / E.
- Boerwinkle, G. Utermann // Am. J. Hum. Genet. 1988. Vol. 42. — P. 104−122.
- Boisvert W.A. Elimination of macrophage specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6 J male mice / W.A. Boisvert, L.K. Curtiss // J. Lipid. Res. 1999. Vol. 40. — P.806−813.
- Brand K. Interferon у inhibits macrophage apolipoprotein E production by posttranslational mechanisms / K. Brand, N. Mackman, L. Curtiss // J. Clin. Invest. 1993. Vol. 91. — P.2031−2039.
- Breslow J.L. Genetics of the human apolipoproteins. In Biochemistry and Biology of Plasma Lipoproteins / J.L. Breslow. New York, 1986. — P.85−143.
- Brouwer D.A. Clinical chemistry of common apolipoprotein E isoforms / D.A. Brouwer, J.J. van Doormaal, F.A. Muskiet // J. Chromatogr. B. Biomed. Appl.- 1996. Vol. 678, № 1.-P.23−41.
- Brown M.S. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis / M.S. Brown, J.L. Goldstein // Annu. Rev. Biochem. 1983. — Vol. 52. — P.220−223.
- Polymorphism of the apolipoprotein E gene, and. early carotid atherosclerosis defined by ultrasonography in asymptomatic adults / L. Cattin, M. Fisicaro, M. Tonizzo, M. Valenti et.al. // Arterioscler. Thromb. Vase. Biol. -1997. Vol. 17. P.91−94.
- Gene dose of apolipoparotein E type 4 allele and the risk of Alzheimer’s disease in late onset fsmilies / E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel et.al. // Science. 1993. Vol. 261. — P.921−923.
- Cumming A.M. Polymorphism at the apo E locus in relation to risk of coronary disease / A.M. Cumming, F. Robertson // Clin. Genet. 1984. Vol. 25. -P.310−313.
- Dallongeville J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis / J. Dallongeville, J. Lussier Cacan S., J. Davignon // J. Lipid. Res. 1992. Vol. 33. — P.447−54.
- Structure of the hepatic control region of the human apolipoprotein E/C-I gene locus / Q. Dang, D. Walker, S. Taylor et.al. // J. Biol. Chem. 1995. Vol. 270, № 38. — P.22 577−85.
- Davignon J. Apolipoprotein E polymorphism and atherosclerosis / J. Davignon, R.E. Gregg, C.F. Sing // Atherosclerosis. 1988. Vol. 8. -P.l-21.
- Davignon J. Apolipoprotein E polymorphism and atherosclerosis. New Horizons in Coronary Heart Disease / J. Davignon, G.V.R. Born, C.J. Schwartz // Current. Science- 1993. Vol. 5. P. l-21.
- New insight into the association of apolipoprotein E genetic variants with carotid plaques and intima-media thickness / S. Debette, J.C. Lambert, J. Gariepy, N. Fievet et.al. // Stroke. 2006. Vol. 37. — P.2917−2923.
- Dietschy J.M. Cholesterol synthesis in the squirrel monkey: Relative rates of synthesis in various tissues and mechanisms of control / J.M. Dietchy, J.D. Wilson // J. Clin. Invest. 1968. — Vol. 47, № 1. — P. 166−174.
- Dyer C.A. A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor / C. A Dyer, L. K Curtiss // J. Biol. Chem. 1988. Vol. 263. — P.10 965−73.
- Dyer C.A. Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis / C. A Dyer, L. K Curtiss // J. Biol. Chem. 1991. Vol. 266. -P.22 803−6.
- Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations / C. Ehnholm, M. Lukka, T. Kuusi, E. Nikkila et.al. // J. Lipid. Res. 1986. Vol. 27. — P.227−35.
- Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review / J.E. Eichner, S.T. Dunn, G. Perveen, D.M. Thompson et.al. // Am. J. Epidemiol. -2002. Vol. 155. P.487−495.
- Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease / J.E. Eichner, L.H. Kuller, T.J. Orchard, G.A. Grandits et.al. // Am. J. Cardiol. 1993. Vol. 71. — P. 160−5.
- Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study / R. Elosua, J.M. Ordovas, L.A. Cupples, C.S. Fox et.al. // J. Lipid. Res. 2004. Vol. 45. — P. 1868−1875.
- Apolipoprotein E polymorphism and hyperlipemia in type II diabetics / M. Eto, K. Watanabe, Y. Iwashima, A. Morikawa et.al. // Diabetes. 1986. Vol. 35. — P.1374−82.
- Eto M. Increased frequencies of apolipoprotein e2 and e4 alleles in patients with ischemic heart disease / M. Eto, K. Watanabe, I. Makino // Clin Genet. 1989. Vol. 36. — P.183−188.
- Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages / S. Fazio, V.R. Babaev, A.B. Murray, А.Ы. Hasty, K.J. Carter et.al. // Proc. Natl. Acad. Sci. USA. 1997. Vol. 94. -P.4647−4652.
- Fazio S. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E (Arg 112, Cysl42) / S. Fazio, D.A. Sanan, Y.L. Lee et.al. // Arterioscler. Thromb. 1994. Vol. 14. -P. 1873−1879.
- Recycling of apolipoprotein E in mouse liver / S. Fazio, M.F. Linton, A.H. Hasty, L.L. Swift // J. Biol. Chem. 1999. Vol. 274. — P.8247−8253.
- Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver / Т.Е. Felker, M. Fainaru, R.L. Hamilton, R.J. Havel // J Lipid Res. 1977. Vol. 18. — P.465−73.
- Francke U. Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease / U. Francke, M.S. Brown, J.L. Goldstein // Proc. Natl Acad. Sci. USA. -1984. Vol. 81. P.2826−30.
- Fridewald W. T Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge / W.T.
- Fridewald, R.I. Levy, D.S. Fredrickson // Clin. Chem. 1972. Vol. 18. — P.499−502.
- Goldberg I.J. Lipoprotein lipase and lipolisis central roles in lipoprotein metabolism and atherogenesis / I.J. Goldberg // J. Lipid. Res. 1996. — Vol. 37. -P.693−707.
- Gough P.J. Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector / P.J. Gough, E.W. Raines // Blood. -2003. Vol. 101. — P.485−491.
- The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations / D.M. Hallman, E. Boerwinkle, N. Saha, C. Sandholzer, et.al. //Am. J. Hum. Genet. 1991. Vol. 49. — P.338−349.
- Retroviral gene therapy in apoE-deficient mice: apoE expression in the artery wall reduces early foam cell lesion formation / A.H. Hasty, M.F. Linton, S.J. Brandt, V.R. Babaev et.al. // Circulation. 1999. Vol. 99. — P.2571−2576.
- Heng C.K. Lack of association of apolipoprotein E polymorphism with plasma Lp (a) levels in the Chinese / C.K. Heng, N. Saha, J.S. Tay // Clin. Genet. 1995. Vol. 48.-P.l 13−9.
- ITison J.E. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal / J.E. Hison and D.T. Vernier J. // J. Lipid. Res. 1990. Vol. 31. — P.545−548.
- Hui D.Y. Inhibition of calcium accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins / D.Y. Hui, J.A.K. Harmony // Proc. Natl. Acad. Sci. USA. 1980. Vol. 77. — P.4764−4768.
- Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis / J. Hulthe, J. Wikstrand, H. Emanuelsson, O. Wiklund et.al. // J. Stroke. 1997. Vol. 28.-P. 1189−94.
- Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men / E. Ilveskoski, A. Loimaala, M.F. Mercuri, T. Lehtimaki et.al. // Atherosclerosis. 2000. Vol. 153. — P. 147 153.
- Apolipoprotein E inhibition of mitogen-activated Tlymphocytes: production of interleukin 2 with reduced biological activity / M.E. Kelly, M.A. Clay, M.J. Mistry, H.M. Hsieh-Li, J.A. Harmony // Cell. Immunol. 1994. Vol. 159. — P.124−139.
- Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels / S. M de Knijff P., M. Rosseneu, J. Bury, E. Klasen, et.al. // Hum. Genet. 1988. Vol. 80. — P.287−292.
- Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness / K. Kogawa, Y. Nishizawa, M. Hosoi, T. Kawagishi et.al. //Diabetes. 1997. Vol. 46. -P.682−7.
- Apolipoprotein E gene e2/e3/e4 polimorphism and myocardial infarction: Case-control study in a large population sample / W. Kohc, P. Hoppmann, A. Schomig, A. Kastrati // J. Cardiol. 2008. Vol. 125. — P. 116−117.
- Association of apolipoprotein E polymorphism with myocardial infarction in greek patients with coronary artery disease / G. Kolovou, N.
- Yiannakouris, M. Hatzivassiliou, J. Malakos et.al. // Curr. Med. Res. Opin. 2002. Vol. 18.-P.l 18−124.
- Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients / T. Kuusi, M.S. Nieminen, C. Ehnholm, H. Yki-Jarvinen et.al. // Arteriosclerosis. 1989. Vol. 9.-P.237−41.
- Larkin L. Regulation of apolipoprotein E production in macrophages / L. Larkin, L.M. Khachigian, W. Jessup // Int. J. Mol. Med. 2000. Vol. 6. — P.253−258.
- Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study / T. Lehtimaki, T. Moilanen, J. Viikari, C. Ehnholm et.al. // J. Lipid. Res. 1990. Vol. 31. — P.487−95.
- Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease / H.J. Lenzen, G. Assmann, R. Buchwalsky, H. Schulte // Clin. Chem. 1986. Vol. 32. — P.778−781.
- Hepatic apoE expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor / M.F. Linton, A.H. Hasty, V.R. Babaev, S. Fazio // J Clin Invest. 1998. Vol. 101. — P. 1726−1736.
- Linton M.F. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation / M.F. Linton, J.B. Atkinson, S. Fazio // Science. 1995. Vol. 267. P.1034−1037.
- Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study / G. Luc, J.M. Bard, D. Arveiler, A. Evans et.al. //Arterioscler. Thromb. 1994. Vol. 14. — P. 1412−9.
- Effects of polymorphism on the microenvironment of the LDL receptorbinding region of human apoE / S. Lund-Katz, S. Wehrli, M. Zaiou, Y. Newhouse et.al. // J. Lipid. Res. 2001. Vol. 42. — P.894−901.
- Turkish Heart Study: lipids, lipoproteins, and apolipoproteins / R.W.
- Mahley, K.E. Palaogiu, Zerrin At&, J. Dawaon-Pepin et.al. // J. Lipid. Research. -1995. Vol. 36.-P.839−859.
- Meimanaliev T.S. Prevalense of ischemic heart disease risk factors among the male population in Frunze aged 40−59 years and results of a five-year prevention programme / T.S. Meimanaliev, E.A. Shleifer et.al. // Cor. et Vasa. -1991.-V. 33. P.451−457.
- Menzel II.J. Apolipoprotein E polymorphism and coronary artery disease / H.J. Menzel, R.G. Kladetzky, G. Assmann // Arteriosclerosis. 1983. Vol. 3. -P.310−5.
- Miyata M. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides / M. Miyata, J.D. Smith // Nat. Genet. 1996. Vol. 14. — P.55−61 340.
- Crosslinking of apolipoprotein E by products of lipid peroxidation / T. J Montine, D.Y. Huang, W.M. Valentine, V. Amarnath et.al. // J. Neuropathol. Exp. Neurol. 1996. Vol. 55. — P.202−10.
- ApoE plasma levels and risk of cardiovascular mortality in ol age / S.P.
- Mooijaart, J.F.P. Berbee, D. van Heemst, L.M. Havekes et.al. // J. PLoS. Med2006. Vol. 3. P.0874−0882.
- Plasma levels of Apolipoprotein E and cognitive function in old age Ann / S.P. Mooijaart, P.V. Vliet, D.V. Heemst, P.C.N. Rensen et.al. // N.Y. Acad. Sci.2007. Vol. 1100. — P.140−147.
- Effect of human apoE4 on the clearance of chylomicron-Iike lipid emulsions and atherogenesis in transgenic mice / B.C. Mortimer, T.G. Redgrave, E.A. Spangler, et.al. // Arterioscler. and Thromb. 1994. Vol. — № 14. -P.1542−1552.
- Murray C.J.L. Alternative projections of mortality and disability by cause 1990−2020: global burden of disease study / C.J.L. Murray, A.D. Lopez // Lancet. 1997. Vol. 349. — P. 1498−1504.
- ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels / M.C. Neale, P. de Knijff, L.M. Havekes, D.I. Boomsma // Genet Epidemiol. 2000. Vol. 18. — P.331−340.
- Quantitation of apolipoprotein E mRNA in the liver and peripheraltissues of non-human primates / T. Newman, P. Dawson, L.L. Rudel, D.L. Williams // J. Biol. Chem. 1985. Vol. 260. — P.2452−2457.
- Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults / D.H. O’Leary, J. F: Polak, R.A. Kronmal, T.A. Manolio et.al. //N. Engl. J. Med. 1999. Vol. 340. — P. 14−22.
- Nucleotide sequence and structure of the human apolipoprotein E gene / Y-K Paik, D.J. Chang, C.A. Reardon, G.E. Davies et.al. // Proc. Natl. Acad. Sci USA. 1989. — Vol. 82. — P.3445−3449.
- Panin L.E. Detection of Apolipoprotein A-I, В and E Immunoreactivity in the Nuclei of Various Rat Tissue Cells / L.E. Panin, Russkikh anl L.M. Polyakov // Biochemistry (Moscow). 2000. — Vol. 65, № 12. — P.1419−1423.
- Association Between Apolipoprotein E Genotype and Carotid Intima-Media Thickness May Suggest a Specific Effect on Large Artery Atherothrombotic Stroke / L. Paternoster, N.A.M. Gonzalez, S. Lewis, C. Sudlow // Stroke. 2008. Vol. 39. — P.48−54.
- Linkage studies in familial Alzheimer’s disease: evidence for chromosome 19 linkage / M.A. Perical-Vance, J.L. Bebout, P.C. Gaskell, L.H. Yamaoka et.al. // Am.J.Hum.Genet. 1991. Vol. 48. — P.1034−1050.
- Linkage studies in familial Alzheimer’s disease: evidence for chromosome 19 linkage / M.A. Perical-Vance, J.L. Bebout, C.A. Haynes, P.C. Gaskell et.al. // Am.J.Hum.Genet. 1990. V. 47. — P. 194.
- Prevention of coronary heart disease in clinical practice /
- Recommendation of the Second Joint Task Force of the European and other Societies on Coronary Prevention // J. Eur. Heart. 1998. Vol. 19. — P. 1434−503.
- Carotid intima-media thickness is different in large- and small-vessel ischaemic stroke: the SMART study / M.O. Pruissen, S.A.M. Gerritsen, T.J. Prinsen, J.M. Dijk et.al. // Stroke. 2007. Vol. 38. — P.1371−1373.
- Raill S.C. Human apolipoprotein E. The complete amino acid sequence / S.C. Rail Jr, K.H. Weisgraber, R.W. Mahley // J. Biol. Chem. 1982. Vol. 257. -P.4171−8.
- Expression of the human apolipoprotein E gene in cultured mammalian cells / C.A. Reardon, Y.F. Lau, Y.K. Paik, K.H. Weisgraber et.al. // J. Biol. Chem. 1986. Vol. 261.-P.9858−64.
- Identification and characterisation of LRP8 (apoER2) in human blood platelets / D.R. Riddell, D.V. Vinogradov, A.K. Stannard, N. Chadwick, J.S. Owen//J. Lipid. Res. 1999. Vol. 40. — P.1925−1930.
- Riddell D.R. Apolipoprotein E inhibits platelet aggregation through the L-arginine: nitric oxide pathway. Implications for vascular disease / D.R.
- Riddell, A. Graham, J.S. Owen // J. Biol. Chem. 1997. Vol. 272. — P.89−95.
- Abundant expression of apolipoprotein E by macrophages in human and rabbit atherosclerotic lesions / M.E. Rosenfeld, S. Butler, V.A. Ord, B.A. Lipton et.al.//Arterioscler. Thromb. 1993. Vol. 13. — P.1382−1389.
- Familial apolipoprotein E deficiency / E.J. Schaefer, R.E. Gregg, G. Ghiselli, T.M. Forte et.al. // J. Clin. Invest. 1986. Vol. 78. — P.1206−1219.
- Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall / II. Shimano, J. Ohsuga, M. Shimanda, M. Kawamura et.al. // J. Clin. Invest. 1995. Vol. 95. — P.469−476.
- Apolipoprotein E: An important gene and protein to follow in laboratory medicine / G. Siest, T. Pillot, A. Regis-Bailly, B. Leininger-Muller et.al. // Clin. Chem.- 1995. Vol. 41. P.1068−1086.
- Apolipoprotein E and carotid artery atherosclerosis: The Rotterdam study / A.J.C. Slooter, M.L. Bots, L.M. Havekes, D.S. Iglesias et.al. // Stroke. -2001. Vol. 32. P.1947−1952.
- Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men / J.IT. Stengard, K.E. Zerba, J. Pekkanen, C. Ehnholm et.al. // Circulation. 1995. Vol. 91. — P.265−269.
- APOE polymorphism and lipid profile in three ethnic groups in the Singapore population / C.E. Tan, E.S. Tai, C.S. Tan, K.S. Chia et.al. // Atherosclerosis. -2003. Vol. 170. P.253−60.
- Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening / J.G. Terry, G. Howard, M. Mercuri, M.G. Bond, J.R. Crouse // Stroke. 1996. Vol. 27. — P. 1755−1759.
- Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice / F.E.
- Thorngate, L.L. Rudel, R.L. Walzem, D.L. Williams // Arterioscler. Thromb. Vase. Biol. 2000. Vol. 20. — P.1939−1945.
- Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression / F.E. Thorngate, P.G. Yancey, G. Kellner-Weibel, L.L. Rudel et.al. // J. Lipid. Res. 2003. Vol. 44. -P.2331−2338.
- Thurberg B.L. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells / B.L. Thurberg, C.A. Reardon, G.S. Getz // J. Biol. Chem. 1996. Vol. 271(11). — P.6062−70.
- Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice / K. Tsukamoto, R.K. Tangirala, S. Chun, D. Usher et.al. // Mol. Ther. -2000. Vol. 1.- P. 189−194.
- General model to describe the structure and dynamic balance between different human serum lipoproteins and its practical application^ / F.V.
- Tuzikov, N.A. Tuzikova, R.L. Galimov, L.E. Panin, G.A. Nevinsky // Med. Sci. Monit. 2002. — Vol. 8, № 4. — P.2−11.
- Utermann G. Apolipoprotein E morphism in health and disease / G.
- Utermann // Am. Heart J. 1987. Vol. 113. — P.433−440.
- Utermann G. Apolipoprotein E phenotypes in patients with myocardial infarction / G. Utermann, A. Hardewig, F. Zimmer // Hum. Genet. 1984. Vol. 65. — P.237−41.
- Utermann G. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis / G.
- Utermann, A. Steinmetz and W. Weber // Hum. Genet. 1982. Vol. 60. — P.344−351.
- Genetics of the apolipoprotein E system in man / G. Utermann, U. Langenback, U. Beisiegel and W. Weber // Am. J. Hum. Genet. 1980. Vol. 32. -P.339−347.
- Accelerated atherosclerosis in C57BL/6 mice transplanted with ApoE-deficient bone marrow / M. Van Eck, N. I-Ierijgers, M. Vidgeon-Hart, N.J. Pearce et.al. // Atherosclerosis. 2000. Vol. 150. — P.71 -80.
- Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects / I. Vauhkonen, L. Niskanen, M. Ryynanen, R. Voutilainen et.al. // Diabet. Med. 1997. Vol. 14. -P.748−56.
- Wang X.L. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography / X.L. Wang, R.M. Mc. Credie, D.E. Wilcken //Arterioscler. Thromb. Vase. Biol. 1995. Vol. 15. — P. 1030−4.
- Weisgraber K.H. Abnormal lipoprotein receptor-binding activity of the human apoE apoprotein due to cysteine-arginine interchange at a single site / K.H. Weisgraber, T.L. Innerarity and R.W. Mahley // J. Biol. Chem. 1982. Vol. 257. -P.2518−2521.
- Apolipoprotein E alleles and risk of coronary disease. A meta-analysis / P.W. Wilson, E.J. Schaefer, M.G. Larson, J.M. Ordovas // Arterioscler. Thromb. Vase. Biol. 1996. Vol. 16. — P.1250−5.
- Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring study / P.W. Wilson, R.H. Myers, M.G. Larson, J.M. Ordovas et.al. //J. Am. Med. Assoc. 1994. Vol. 272. — P. 1666−71.
- Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study / P.W.F. Wilson, R. H Myers, M.G. Larson, J.M. Ordovas et.al. // JAMA. 1994. Vol. 272. — P. 1666−1671.
- Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits / N.
- Yamada, H. Shimano, H. Mokuno, S. Ishibashi et.al. // Proc. Natl. Acad. Sci. U.S.A. 1989. Vol. 86. — P.665−669.
- Yamamura T. Apolipoprotein E polymorphism and coronary heart disease
- T. Yamamura, L.M. Dong, A. Yamamoto // J. Chin. Med. 1992. Vol. 105(9). -P.738−41.
- Zannis V.I. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification / V.I. Zannis, J.L. Breslow // Biochemistry. 1981. V. 20. — P.1033−1041.